antithrombotic drugs

DRUG3 trials

Sponsors

St. Olavs Hospital, Xijing Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions

Intracranial HemorrhagesIschemic StrokePalliative CareStroke

Unknown Phase

Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs

CompletedNCT02481011

St. Olavs HospitalIntracranial Hemorrhages, Stroke

Start: 2015-05-31End: 2016-01-01Updated: 2018-08-28

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

RecruitingNCT05032053

Xijing HospitalIschemic Stroke

Start: 2022-03-01End: 2027-12-01Target: 3000Updated: 2026-07-30

Antithrombotic Therapy at the End of Life: The PEACE Study

Not yet recruitingNCT07338071

Fondazione Policlinico Universitario Agostino Gemelli IRCCSPalliative Care

Start: 2026-01-31End: 2027-11-30Target: 410Updated: 2026-01-13

Related Papers

Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study

PLoS ONE2018-08-2353 citations

Referee report. For: Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study [version 1; referees: 1 approved]

Faculty of 1000 Research Ltd2016-01-01

Referee report. For: Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study [version 1; referees: 2 approved]

Faculty of 1000 Research Ltd2016-01-01

Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study.

2015-12-303 citations